
CAS Number3521-62-8
SynonymsErythromycin Estolate; Erythromycin 2'-propionate dodecyl sulfate; Erythromycin 2′-propionate dodecyl sulfate; Erythromycin 2-Propionate Dodecyl Sulfate
Molecular FormulaC40H71NO14 · C12H26SO4
Molecular Weight1056.39
Purity98%
Density1.0053 (rough estimate)
Boiling Point827.7ºC at 760 mmHg
Melting Point135-140ºC dec.
Appearancesolid
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 3521-62-8 |
| Catalog No. | 2A-9010372 |
| Chinese Name | 依托红霉素 |
| Synonyms | Erythromycin Estolate; Erythromycin 2'-propionate dodecyl sulfate; Erythromycin 2′-propionate dodecyl sulfate; Erythromycin 2-Propionate Dodecyl Sulfate |
| Molecular Formula | C40H71NO14 · C12H26SO4 |
| Molecular Weight | 1056.39 |
| Purity | 98 |
| Density | 1.0053 (rough estimate) |
| Boiling Point | 827.7ºC at 760 mmHg |
| Melting Point | 135-140ºC dec. |
| Appearance | solid |
| Water Solubility | chloroform: soluble4.0ML, clear, colorless (200 mg |
| Storage Condition | -20°C Freezer |
| Application | Erythromycin estolate is an erythromycin derivative, a macrolide antibiotic used to treat a variety of bacterial infections. Erythromycin estolate has caused several cases of liver injury, mainly chol |
| HTC | 29419000 |
| PubChem ID | 329749384 |
| MDL Number | MFCD00084691 |
| SMILES | CCCCCCCCCCCCOS(O)(=O)=O.CC[C@H]1OC(=O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(O)C[C@H](C)C(=O)C(C)[C@@H](O)[C@@]1(C)O |
| InChI | 1S/C37H67NO13.C12H26O4S/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2-12H2,1H3,(H,13,14,15)/t18-,19+,20?,21+,22-,23-,24-,25?,26-,28+,29+,30+,31-,32-,34-,35-,36+,37+;/m0./s1 |
| InChI Key | SKDGGFHGLZBNBC-CAHOBLCESA-N |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| MSDS | msds/10372_1_3521_62_8.pdf |
| Bioactivity | Erythromycin estolate, erythromycin derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin estolate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin estolate toxicity is related to its inhibitory effect on bile acid transport[2]. Related Catalog Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial References [1]. David E. Kleiner, et al. Learn more about Erythromycin Estolate. Biomaterials and Medical Device - Associated Infections, 2015 [2]. Lu X, et al. Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat. Food Chem Toxicol. 2014 Mar;65:343-55. Chemical & Physical Properties Density 1.0053 (rough estimate) Boiling Point 827.7ºC at 760 mmHg Melting Point 135-140ºC dec. Molecular Formula C52H97NO18S Molecular Weight 1000.324 Flash Point 454.4ºC Exact Mass 999.616394 PSA 271.96000 LogP 7.55400 Index of Refraction 1.6550 (estimate) InChIKey AWMFUEJKWXESNL-PKUOEACZSA-N SMILES CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1N(C)C.CCCCCCCCCCCCOS(=O)(=O)O Storage condition -20°C Freezer Water Solubility chloroform: soluble4.0ML, clear, colorless (200 mg + 4.0 mL Chloroform) |
| Use of | Erythromycin estolate, erythromycin derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin estolate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin estolate toxicity is related to its inhibitory effect on bile acid transport[2]. Properties Articles28 Name erythromycin estolate Synonym More Synonyms Erythromycin Estolate Biological Activity Description Erythromycin estolate, erythromycin derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin estolate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin estolate toxicity is related to its inhibitory effect on bile acid transport[2]. Related Catalog Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial References [1]. David E. Kleiner, et al. Learn more about Erythromycin Estolate. Biomaterials and Medical Device - Associated Infections, 2015 [2]. Lu X, et al. Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat. Food Chem Toxicol. 2014 Mar;65:343-55. Chemical & Physical Properties Molecular Formula C52H97NO18S Exact Mass 999.616394 PSA 271.96000 LogP 7.55400 Index of Refraction 1.6550 (estimate) InChIKey AWMFUEJKWXESNL-PKUOEACZSA-N |
| Transport Info | Product name: Erythromycin eton |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Enrofloxacin | 93106-60-6 | 2A-9010334 |
| Epirubicin | 56420-45-2 | 2A-9010348 |
| Epirubicin hydrochloride | 56390-09-1 | 2A-9010349 |
| Epirubicinol | 2A-301433 | 2A-9010350 |
| Eprosartan | 133040-01-4 | 2A-9010355 |
| Erythromycin propionate | 134-36-1 | 2A-9010373 |
| Erythromycin thiocyanate | 7704-67-8 | 2A-9010374 |
| Escitalopram | 128196-01-0 | 2A-0202054 |
| Estriol | 50-27-1 | 2A-9010388 |
| Ethambutol | 74-55-5 | 2A-9010395 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA